LeMaitre Vascular Inc  

(Public, NASDAQ:LMAT)   Watch this stock  
Find more results for LMAT
6.58
0.00 (0.00%)
Jun 19 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 5.25 - 6.75
Open     -
Vol / Avg. 0.00/18,914.00
Mkt cap 100.34M
P/E 33.91
Div/yield 0.03/1.82
EPS 0.19
Shares 15.25M
Beta 0.38
Inst. own 36%
Jul 29, 2013
Q2 2013 LeMaitre Vascular, Inc. Earnings Release Add to calendar
Jun 19, 2013
LeMaitre Vascular, Inc. at Wells Fargo Health Care Conference
Jun 13, 2013
LeMaitre Vascular, Inc. Annual Shareholder Meeting
Jun 7, 2013
LeMaitre Vascular, Inc. at Sidoti & Company Semi Microcap Conference
May 30, 2013
LeMaitre Vascular, Inc. at Marcum MicroCap Conference
May 30, 2013
LeMaitre Vascular, Inc. at 38th Annual dbAccess Health Care Conference
May 16, 2013
LeMaitre Vascular, Inc. at Bank of America Merrill Lynch Health Care Conference
May 15, 2013
LeMaitre Vascular, Inc. at Three Part Advisors East Coast IDEAS Investor Conference
Apr 30, 2013
LeMaitre Vascular, Inc. at Needham Healthcare Conference
Apr 30, 2013
Q1 2013 LeMaitre Vascular, Inc. Earnings Conference Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin 5.50% 4.53%
Operating margin 7.30% 7.47%
EBITD margin - 11.15%
Return on average assets 5.37% 4.19%
Return on average equity 6.39% 4.90%
Employees 301 -
Carbon Disclosure Rating - -

Address

63 Second Avenue
BURLINGTON, MA 01803
United States - Map
+1-781-2212266 (Phone)
+1-781-2212223 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

LeMaitre Vascular, Inc. (LeMaitre Vascular), is a global provider of medical devices and implants for the treatment of peripheral vascular disease. The Company develops, manufacture, and market vascular devices to addresses the needs of vascular surgeons. The Company's diversified portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart and are well known to vascular surgeons, including the Expandable LeMaitre Valvulotome, the Pruitt F3 Carotid Shunt, and VascuTape Radiopaque Tape. It sells 12 product lines. In June 2011, it divested its TAArget and UniFit stent grafts to Duke Vascular, Inc. In August 2011, it terminated its distribution of Endologix�s aortic stent graft products in Europe. In November 2011, it launched the second-generation of The UnBalloon Non-Occlusive Modeling Catheter. In December 2011, it launched the Over-The-Wire LeMaitre Valvulotome.

Officers and directors

George W. LeMaitre Chairman of the Board, Chief Executive Officer
Portrait. Age: 47
Bio & Compensation  - Reuters
David B. Roberts President, Director
Age: 48
Bio & Compensation  - Reuters
Joseph P. Pellegrino Jr. Chief Financial Officer
Age: 47
Bio & Compensation  - Reuters
Peter R. Gebauer President - International Operations
Age: 58
Bio & Compensation  - Reuters
Robert V. Linden Senior Vice President - Sales, The Americas
Age: 45
Bio & Compensation  - Reuters
Trent G Kamke Senior Vice President - Operations
Age: 41
Bio & Compensation  - Reuters
Maik D. Helmers Vice President - Sales, Central Europe
Age: 38
Bio & Compensation  - Reuters
Kimberly L Cieslak Vice President - Marketing
Age: 39
Bio & Compensation  - Reuters
Wolfgang Meichelboeck Vice President - Marketing International
Age: 55
Bio & Compensation  - Reuters
Cornelia W. LeMaitre Vice President - Human Resources, Director
Age: 76
Bio & Compensation  - Reuters